About Meadowhawk Biolabs
Meadowhawk Biolabs is a private company based in Marlborough, Massachusetts, incorporated in 2021 in Delaware. It has reported $20,250,000 raised in three offerings on Form D since March 2023. Its chief executive is James Jersey.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 1, 2024 | Jul 16, 2024 | $5,000,000fully sold | 8 | $625K | EquityRule 506(b) | Form D ↗ |
| Aug 9, 2021 | Mar 17, 2023 | $9,250,000fully sold | 8 | $1.1M | EquityRule 506(b) | Form D ↗ |
| Mar 3, 2023 | Mar 17, 2023 | $6,000,000fully sold | 9 | $666K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $20,250,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Meadowhawk Biolabs's Form D filed Jul 16, 2024.
PG
Peter Glick
Executive officer and director
JJ
James Jersey
Chief Executive Officer and director
JS
Jessica Sullivan
Executive officer
HH
Herbert Hooper
Director